In the study in 2023 analyzed the expression of anticancer genes (NOXA, PAR-4, TRAIL) in colorectal cancer (CRC) and their induction by riproximin, a ribosomal-inactivating plant protein. This evidence concerns the gene TNFSF10 and colorectal carcinoma.